METiS Pharmaceuticals
METiS Pharmaceuticals is a biotechnology company leveraging AI, machine learning, and quantum simulation for drug delivery and discovery. Their interdisciplinary approach integrates these technologies with high-throughput experimentation to develop novel therapies across various diseases. The company has an independent pipeline of over 10 drugs, including small molecule and RNA drugs, and engages in joint development and external licensing with global pharmaceutical partners. Key personnel include Co-founder, President and Head of R&D, Dr. Hongming Chen, and CSO Dr. Wei Xu, with the CEO Dr. Chris Lai actively participating in industry conferences.
METiS Pharmaceuticals
METiS Pharmaceuticals is a biotechnology company leveraging AI, machine learning, and quantum simulation for drug delivery and discovery. Their interdisciplinary approach integrates these technologies with high-throughput experimentation to develop novel therapies across various diseases. The company has an independent pipeline of over 10 drugs, including small molecule and RNA drugs, and engages in joint development and external licensing with global pharmaceutical partners. Key personnel include Co-founder, President and Head of R&D, Dr. Hongming Chen, and CSO Dr. Wei Xu, with the CEO Dr. Chris Lai actively participating in industry conferences.